About Index Trending news
Lists
Pricing
Repare Therapeutics

Repare Therapeutics

Repare Therapeutics

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$68,000,000
Employees

Unknown size

Locations
HQ
Headquarters
$68,000,000 Venture capital (Series A)
Fundnews , 4-traders

Quebec's Repare Therapeutics raises $68M in Series A funding